Matthias Schiedel

24PUBLICATIONS
83CO-AUTHORS
Biologically active moleculesToxicology (incl. clinical toxicology)Cheminformatics and quantitative structure-activity relationshipsCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Oct 30, 2025
From Pharmacophore to Warhead: NAD+-Targeting Triazoles as Mechanism-Based Sirtuin Inhibitors.

Florian Friedrich, Marat Meleshin, Niklas Papenkordt

|Oct 07, 2025
A Warm Welcome to MedChem: The Frontiers in Medicinal Chemistry 2025.

Matthias Schiedel, Marta Pinto, Andrea Unzue Lopez

|Sep 19, 2025
Target Engagement Studies and Kinetic Live-Cell Degradation Assays Enable the Systematic Characterization of Histone Deacetylase 6 Degraders.

Maria Hanl, Felix Feller, Irina Honin

|Aug 25, 2025
A Warm Welcome to MedChem: The Frontiers in Medicinal Chemistry 2025.

Matthias Schiedel, Marta Pinto, Andrea Unzue Lopez

|May 20, 2025
Efficient Crystallization of Apo Sirt2 for Small-Molecule Soaking and Structural Analysis of Ligand Interactions.

Florian Friedrich, Matthias Schiedel, Sören Swyter

|Apr 09, 2025
Antiproliferative effects, mechanism of action and tumor reduction studies in a lung cancer xenograft mouse model of an organometallic gold(i) alkynyl complex.

Uttara Basu, Anna Wilsmann, Sebastian Türck

Pageof 4

Frequent Collaborators

8 joint publications

Max E Huber

7 joint publications

Lara Toy

7 joint publications

Manfred Jung

6 joint publications

Finn K Hansen